Comparison of Renal Osteodystrophy in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis and Hemodialysis

Smith A.J. , Faugere M.C. , Abreo K. , Fanti P. , Julian B. , Malluche H.H. Aluminum-related bone disease in mild and advanced renal failure: Evidence for high relapse and morbidity, and studies on etiology and diagnosis in 197 patients. Am J Nephrol 1986; 6: 275–83.

Eisman J.A. , Hamstra A.J. , Kream B.E. , Deluca H.F. 1,25-dihydroxyvitamin D in biological fluids: Simplified and sensitive assay. Science 1976; 193: 1021–3.

Kanis J.A. , Hamdy N.A.T. , McCloskey E.V. : Hypercalcemia and hypocalcemia. In: Cameron S. , Davison A.M. , Grunfeld J.P. , eds. Oxford textbook of clinical nephrology. New York: Oxford University Press, 1992; 1753–82.

Hercz G. , Pei Y. , Manuel A. Aplastic osteodystrophy without aluminum staining in dialysis patients (Abstract). Kidney Int 1990; 37: 449.

Shusterman N.H. , Wasserstein A.G. , Morrison G. , Audet P. , Fallon M.D. , Kaplan F. Controlled study of renal osteodystrophy in patients undergoing dialysis. Am J Med 1987; 82: 1148–56.

Delmez J.A. , Slatopolsky E. , Martin K.J. , Gearing B.N. , Harter H.R. Minerals, vitamin D and parathyroid hormone in continuous ambulatory peritoneal dialysis. Kidney Int 1982; 21: 862–7.

Fremont J.F. , Moriniere P. , Decourcell P.M. , Roussal R. , Makdassi R. , Fournier A. Control of hyperparathy roidism by CAPD. Kidney Int 1982; 21: 211.

Teitelbaum S. , Fallon M.D. , Gearing G. , Dougan C.S. , Delmez J. The effects of CAPD on bone histomorphology. Kidney Int 1982; 21: 180.

Gokal R. , Ramos J.M. , Hewett A.E. Histological renal osteodystrophy, and 25-hydroxycholecalciferol and aluminum levels in patients on continuous ambulatory dialysis. Kidney Int 1983; 23: 15–21.

Cassidy M.J.D. , Owen J.P. , Ellis H.A. Renal osteodystrophy and metastatic calcification in long-term continuous ambulatory dialysis. Q J Med 1985; 54: 29–48.

Loschiavo C. , Fabris A. , Adami S. Effects of CAPD on renal osteodystrophy. Perit Dial Bull 1985; 5: 53–5.

Digenis G. , Khanna R. , Pierratos A. Renal os teodystrophy in patients maintained on CAPD for more than three years. Perit Dial Bull 1983; 3: 81–6.

Nolph K.D. , Ryan L. , Prowant B. , Twardowski Z. A crosssectional assessment of serum vitamin D and triglycerides in a CAPD population. Perit Dial Bull 1984; 4: 232–6.

Kurtz S.B. , McCarthy J.T. , Kumar R. Hypercalcaemia in CAPD patients: Observations on parameters of calcium metabolism. In: Gahl G. , Kessel M. , Nolph K. , eds. Advances in peritoneal dialysis. Amsterdam: Excerta Medica 1981: 467.

Cobum J.W. Renal osteodystrophy. Kidney Int 1980; 17: 677–93.

Zucchelli P. , Catizone L. , Casanova S. , Fusaroli M. , Fabbri L. , Ferrari G. Renal osteodystrophy in CAPD patients. Miner Electrolyte Metab 1984; 10: 326–32.

Ram say M. , Tapson J. , Ward M.K. Comparison of renal osteodystrophy between hemo dialysis and CAPD management of renal failure (Abstract). Perit Dial Int 1989; 9(Suppl 1): 208.

Sherrard D. , Ott S. , Maloney N. , Andress D. , Coburn J. Renal osteodystrophy: Classification, cause and treatment. In: Frame B. , Potts J.J. , eds. Clinical disorders of bone and mineral metabolism. Amsterdam: Excerpta Medica, 1983: 254–9.

Malluche H. , Faugere M. Renal bone disease 1990: An unmet challenge for the nephrologist. Kidney Int 1990; 38: 193–211.

Quarles L. , Gitelman H. , Drezner M. Aluminum: Culprit or accessory in the genesis of renal osteodystrophy? Semin Nephrol 1986; 6: 90–101.

Moriniere P. , Cohen-Salal A. , Belbrik S. Disappearance of aluminic bone disease in a long-term asymptomatic dialysis population restricting Al(OH)3 intake: Emergence of an idiopathic adynamic bone disease not related to aluminum. Nephron 1989; 53: 93–101.

Hutchison A.J. , Whitehouse R.W. , Boulton H.F. Characteristics and natural history of the adynamic bone lesion in CAPD (Abstract). Perit Dial Int 1992; 12(Suppl 2): 879.